Skip to main content
. Author manuscript; available in PMC: 2013 Jan 8.
Published in final edited form as: J Anxiety Disord. 2012 Aug 15;26(8):833–843. doi: 10.1016/j.janxdis.2012.07.009

Table 1.

Non-psychiatrists’ guide to pharmacotherapy interventions for the anxiety disorders.

SP PTSD PD SAD GAD OCD
Selective serotonin reuptake inhibitor (SSRI) 1 1 1 1 1a
Shift to different SSRI or SNRI 2 2 2 2 2
Augmentation with additional SSRI or SNRI 3 3 3 3 3
Other antidepressants (MAOIs, other)c 4 3 3 2 4
Tricyclic antidepressants 3 2 3 3 1b
Augmentation with atypical antipsychotics 4 4 4 4 4
Anticonvulsants 4 4 4
Azapirones 3
Beta blockers 2 3
Benzodiazepines 2 3 3 4

Note: 1 = First-line intervention:multiple randomized control trials (RCTs) showing efficacy.

2 = Secondary intervention:often used as an intervention for non- or partial-response of first-line intervention, with some RCTs showing efficacy, though evidence may be mixed.

3 or 4 = Alternative intervention after 1st and 2nd line interventions, often with less RCT support or more significant side effect profile.

SP = specific phobia; PTSD = posttraumatic stress disorder; PD = panic disorder; SAD = social anxiety disorder; GAD = generalized anxiety disorder; OCD = obsessive–compulsive disorder; SNRI = serotonin norepinephrine reuptake inhibitor; MAOI = monoamine oxidase inhibitor.

a

Higher dosage than for other anxiety disorders.

b

Clomipramine (Anafranil).

c

Examples include bupropion (Wellbutrin), mirtazpine (Remeron), nefazodone (Serzone).